Gsa Capital Partners LLP Horizon Therapeutics Public LTD CO Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $1.2 Million - $1.27 Million	11,208 New	11,208 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $248,171 - $356,630	4,212 Added 75.05%	9,824 $608,000
Q2 2022 Aug 09, 2022	SELL	$79.4 - $116.36 $299,338 - $438,677	-3,770 Reduced 40.18%	5,612 $448,000
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $437,198 - $555,528	5,059 Added 117.03%	9,382 $987,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $203,822 - $247,973	2,068 Added 91.71%	4,323 $466,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $207,257 - $248,884	2,255 New	2,255 $247,000
Q1 2020 May 12, 2020	SELL	$24.87 - $38.56 $159,192 - $246,822	-6,401 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$25.43 - $36.67 $162,777 - $234,724	6,401 New	6,401 $232,000
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $249,619 - $303,558	-10,853 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$22.81 - $28.48 $247,556 - $309,093	10,853 New	10,853 $261,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.